The researchers at VetCell Therapeutics are continuously investigating effective future therapies that utilize both allogeneic and autologous stem cells derived from sources other than adipose tissue, such as bone marrow, blood and various organ tissues, as well as exploring new processing techniques. Our services include banking of cells for later use, ability to culture or grow more cells for retreatment, eliminating the need for pets to withstand multiple adipose tissue biopsies.
VetCell Therapeutics team of scientists have the space and tools necessary to delve deeper into the characterization of stem cells and their respective therapeutic value, and to develop potent treatments, while complying with FDA’s Current Good Manufacturing Practice (CGMP) regulations, ensuring a safe and high quality product for clinical use.
Tom Yuen – Chairman, President, CEO
Mr. Tom Yuen is a proven serial entrepreneur who has founded several successful publicly traded companies including AST Research Inc. and SRS Labs, Inc. Mr. Yuen received his Bachelor of Science degree in Electrical Engineering from the University of California, Irvine in 1974.
He has received many honors including:
• Director of the Year, Orange County Forum for Corporate Directors (1997)
• Top 25 Executives, Consumer Industry, Computer Reseller News Magazine (1991 & 1987)
• The UCI Medal (1990)
• The UCI Outstanding Engineering Alumni Award (1987)
• The UCI Distinguished Alumnus Award (1986)
Fari Izadyar DVM, PhD. – Chief Scientific Officer
Dr. Fari Izadyar is a well renowned scientist in the field of biotechnology and stem cell research. He holds a Doctorate in Veterinary Medicine and a PhD in Reproductive and Stem Cell Biology. He is a seasoned clinician with over twenty-five years of experience as a large animal practitioner and scientist working in the research laboratories of academic and biotech organizations and in private veterinary clinics.
As an expert in cell-based therapy technology, he contributed to development of innovative techniques using a variety of stem cells for regenerative medical applications. Dr. Izadyar has directed many research programs in different disciplines and collaborated with numerous academic and industrial organizations both nationally and internationally. His involvement in clinical research has resulted in publishing numerous papers in peer-reviewed journals that have been presented in Veterinary and Stem cell meetings.
Chad Maki DVM – Chief Medical Officer
Dr. Maki earned his undergraduate degree in Biochemistry from the University of California, Berkeley and his internationally accredited DVM at the University of Edinburgh, Scotland. Since 2005 he has worked extensively in the field of stem cell research and has produced numerous peer reviewed scientific publications. While accomplishing his veterinary degree he continued his scientific interests at Roslin Institute by investigating the role of canine cancer stem cells and the biomechanics of bone growth. After graduating with his DVM he moved back to his home town in Orange County, California and has been practicing veterinary medicine for our furry family companions ever since. He is an associate veterinarian at Irvine Pet Complex in Irvine, CA and is a member of the SCVMA, CVMA, AVMA, VOS, AAFP and iCatCare.
Through his experience in the stem cell field and in the clinical practice setting, Dr. Maki sees the great potential that stem cell therapy can have for various ailments. His aim is to provide state of the art stem cell therapies for our pet patients suffering from various degenerative conditions such as osteoarthritis and chronic kidney disease. His ambition is to have a life-changing impact on these patients that have a great need to eliminate their pain and suffering and improve their quality of life through regenerative therapy technologies. He envisions regenerative therapies as the mainstay of animal and human medicine and is excited to be at the forefront in this field.
Sign up to receive special announcements: